XML 53 R41.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Jul. 07, 2017
Net income (loss) $ (256,000)   $ (1,310,000)  
Cash used in operations 276,000   1,178,000  
Cash and cash equivalents 674,000      
Accumulated deficit (54,600,000)      
Recognize revenue 233,727   211,724  
Allowance for sales returns 227,000   227,000  
Inventory Reserve 1,100,000   1,100,000  
Warranty Reserve 30,000   $ 30,000  
Advertising And Promotional Expenses 31,000 $ 92,000    
Research And Development Expenses 45,000 $ 68,000    
Cash Balances At Financial Institutions $ 250,000      
Shares of common stock outstanding 20,015,205   20,015,205  
Common Stock, Shares Authorized 250,000,000   250,000,000  
2016 Equity Incentive Plan        
Shares of common stock outstanding 5,700,000 5,500,000    
Common Stock, Shares Authorized       2,000,000
Warrants        
Potentially Dilutive Securities 2,604,388 2,772,096    
Convertible debentures        
Potentially Dilutive Securities 2,308,000 2,080,000    
Stock Options        
Potentially Dilutive Securities 768,792 508,042    
Preferred A stock        
Potentially Dilutive Securities 63,750 63,750    
One Vendors | Accounts Payable        
Concentration Risk, Percentage 49.00%   60.00%  
Two Vendors | Cost of Sales [Member]        
Concentration Risk, In Percentage 50.00% 49.00%